ICW Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.91M | Buy |
42,226
+939
| +2% | +$64.8K | 1.15% | 26 |
|
2025
Q1 | $2.87M | Buy |
41,287
+145
| +0.4% | +$10.1K | 1.17% | 23 |
|
2024
Q4 | $3.54M | Buy |
41,142
+472
| +1% | +$40.6K | 1.48% | 15 |
|
2024
Q3 | $4.84M | Sell |
40,670
-827
| -2% | -$98.5K | 2.02% | 6 |
|
2024
Q2 | $5.92M | Sell |
41,497
-843
| -2% | -$120K | 2.69% | 2 |
|
2024
Q1 | $5.44M | Sell |
42,340
-378
| -0.9% | -$48.5K | 2.42% | 2 |
|
2023
Q4 | $4.42M | Sell |
42,718
-1,278
| -3% | -$132K | 2.15% | 4 |
|
2023
Q3 | $4M | Buy |
43,996
+152
| +0.3% | +$13.8K | 2.15% | 4 |
|
2023
Q2 | $3.55M | Buy |
43,844
+126
| +0.3% | +$10.2K | 1.9% | 7 |
|
2023
Q1 | $3.48M | Buy |
43,718
+158
| +0.4% | +$12.6K | 1.98% | 7 |
|
2022
Q4 | $2.95M | Sell |
43,560
-670
| -2% | -$45.3K | 1.77% | 9 |
|
2022
Q3 | $2.2M | Buy |
44,230
+210
| +0.5% | +$10.5K | 1.48% | 14 |
|
2022
Q2 | $2.45M | Sell |
44,020
-62
| -0.1% | -$3.46K | 1.56% | 13 |
|
2022
Q1 | $2.45M | Sell |
44,082
-14
| -0% | -$777 | 1.41% | 14 |
|
2021
Q4 | $2.47M | Buy |
44,096
+138
| +0.3% | +$7.73K | 1.38% | 16 |
|
2021
Q3 | $2.11M | Buy |
43,958
+166
| +0.4% | +$7.97K | 1.36% | 16 |
|
2021
Q2 | $1.83M | Buy |
43,792
+624
| +1% | +$26.1K | 1.2% | 25 |
|
2021
Q1 | $1.46M | Buy |
43,168
+442
| +1% | +$14.9K | 1% | 39 |
|
2020
Q4 | $1.5M | Sell |
42,726
-440
| -1% | -$15.4K | 1.07% | 37 |
|
2020
Q3 | $1.5M | Buy |
43,166
+576
| +1% | +$20K | 1.12% | 35 |
|
2020
Q2 | $1.39M | Buy |
42,590
+258
| +0.6% | +$8.45K | 1.13% | 29 |
|
2020
Q1 | $1.27M | Buy |
42,332
+758
| +2% | +$22.8K | 1.21% | 28 |
|
2019
Q4 | $1.2M | Buy |
+41,574
| New | +$1.2M | 0.98% | 43 |
|